News Releases - Achieve Life Sciences
HOME
ABOUT ACHIEVE
About Achieve
Management Team
Board of Directors
PRODUCTS
Cytisinicline
NEWS
Press Releases
Events
Blog
INVESTORS
CONTACT
HOME
ABOUT ACHIEVE
About Achieve
Senior Management
PRODUCTS
Cytisinicline
NEWS
INVESTORS
CONTACT
News Releases
Home
/
News Releases
Home
ivps4
2017-06-16T21:39:52+00:00
Investors Home
Corporate Governance
News Releases
Financial Information
SEC Filings
Events and Webcasts
Investor Contacts
Investor Alerts
NASDAQ: ACHV
NASDAQ: OGXI
News Releases
Investor Alerts
Year
All Years
2021
2020
2019
2018
2017
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Asset Types
Photos
Video
Audio
Documents
Events
Standard
Dec 19, 2019
Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option
Dec 17, 2019
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
Dec 9, 2019
Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program
Nov 6, 2019
Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program
Oct 31, 2019
Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019
Show
5
10
25
50
100
per page
«
1
…
4
5
6
7
8
9
10
…
20
»
NASDAQ: ACHV
NASDAQ: OGXI
1dy
1mo
6mo
1yr
5yr
Stock Info
NASDAQ: ACHV
NASDAQ: OGXI
Go to Top
